Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Doaa S. Fadaly"'
Publikováno v:
NeuroQuantology. 20:403-416
Background: Sodium-glucose cotransporter-2 (SGLT-2) inhibitor dapagliflozin is a novel antihyperglycemic drug that has cardioprotective effects. It has been shown to minimize the incidence of cardiovascular mortality and heart failure (HF) hospitaliz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1866066d4cfd7df88081637b52aac06
https://doi.org/10.14704/nq.2022.20.4.nq22138
https://doi.org/10.14704/nq.2022.20.4.nq22138
